Drug
Ifetroban sodium clinical trials
A product of Ifetroban; its studies count on that page too.
- studies test it
- 3
- open now
- 1
- in phase 3
- 0
- first study started
- 2018
Keep track of what changes. Save the ifetroban sodium studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Vanderbilt-Ingram Cancer Center (1) · Jeffrey Rade (1) · Cumberland Pharmaceuticals (1)
Studies
Open first, then newest update. How each study uses ifetroban sodium is read from its arms, and is right about nine times in ten.
Testing it · 3
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingPhase 2Cumberland PharmaceuticalsNCT05571059Written as Ifetroban Sodium
- Thromboxane Receptor Antagonist to Improve Endothelial FunctionCompletedPhase 2Jeffrey RadeNCT03962855Written as Ifetroban Sodium
- Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceActive, not recruitingPhase 2Vanderbilt-Ingram Cancer CenterNCT03694249Written as Ifetroban Sodium
Codes
What other systems call ifetroban sodium · ClinicalTrials.gg INT014821
- UNII (FDA) 48IJA0E92CIFETROBAN SODIUMConfirmed FDA, Wikidata
- Wikidata Q27259142ifetroban sodiumConfirmed FDA, Wikidata
- NCI Thesaurus C81569Ifetroban SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 48IJA0E92C | IFETROBAN SODIUM | Confirmed FDA, Wikidata |
| Wikidata | Q27259142 | ifetroban sodium | Confirmed FDA, Wikidata |
| NCI Thesaurus | C81569 | Ifetroban Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.